Literature DB >> 11440391

Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature.

G Samonis1, M Anatoliotaki, H Apostolakou, S Maraki, D Mavroudis, V Georgoulias.   

Abstract

A unique case of Rhodotorula rubra transient fungemia in a post-chemotherapy, febrile neutropenic patient with colon cancer, suffering from gastrointestinal mucositis, is described. The fungus was isolated repeatedly from his blood. However, all signs and symptoms of the infection disappeared, without antifungal treatment, as soon as neutropenia and mucositis, both of short duration, resolved. Restoration of the patient's defense mechanisms was adequate for disappearance of the fungus from the patient's blood and full recovery.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11440391     DOI： 10.1007/s15010-001-1066-1

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  10 in total

1.  Activities of available and investigational antifungal agents against rhodotorula species.

Authors:  D J Diekema; B Petroelje; S A Messer; R J Hollis; M A Pfaller
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Marchiafava-Bignami disease: a rare entity with a poor outcome.

Authors:  Paulo Eduardo Mestrinelli Carrilho; Marcius Benigno Marques Dos Santos; Larisa Piasecki; Amaury Cezar Jorge
Journal:  Rev Bras Ter Intensiva       Date:  2013-03

3.  Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.

Authors:  Maral Gharaghani; Simin Taghipour; Ali Zarei Mahmoudabadi
Journal:  Mol Biol Rep       Date:  2020-11-01       Impact factor: 2.316

4.  Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.

Authors:  Aimee K Zaas; Molly Boyce; Wiley Schell; Barbara Alexander Lodge; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

5.  Antifungal activity of four honeys of different types from Algeria against pathogenic yeast: Candida albicans and Rhodotorula sp.

Authors:  Ahmed Moussa; Djebli Noureddine; Aissat Saad; Meslem Abdelmelek; Benhalima Abdelkader
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

6.  Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.

Authors:  Jorge Meneses Nunes; Fernando César Bizerra; Renata Carmona E Ferreira; Arnaldo Lopes Colombo
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

7.  Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables.

Authors:  R Perniola; M L Faneschi; E Manso; M Pizzolante; A Rizzo; A Sticchi Damiani; R Longo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

8.  Femoral prosthesis infection by Rhodotorula mucilaginosa.

Authors:  Vincenzo Savini; Federica Sozio; Chiara Catavitello; Marzia Talia; Assunta Manna; Fabio Febbo; Andrea Balbinot; Giovanni Di Bonaventura; Raffaele Piccolomini; Giustino Parruti; Domenico D'Antonio
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

Review 9.  Rhodotorula fungemia of an intensive care unit patient and review of published cases.

Authors:  Anastasia Spiliopoulou; Evangelos D Anastassiou; Myrto Christofidou
Journal:  Mycopathologia       Date:  2012-05-11       Impact factor: 2.574

10.  Low sensitivity of conventional fungal agars in fungemia by Rhodotorula mucilaginosa: description of two cases.

Authors:  Carmen Alicia Garcia-Gutiérrez; María Soledad Cuétara-García; María Dolores Moragues; Jorge Ligero; Sara María Quevedo; María José Buitrago
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-03-27       Impact factor: 3.944
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.